MedPath

A study on the clinical features of Oligometastasis in extensive stage small cell lung cancer.

Not Applicable
Conditions
small cell lung cancer
Registration Number
JPRN-UMIN000053402
Lead Sponsor
ational Hospital Organization Hokkaido Cancer Center
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
265
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patients who underwent surgery prior to induction of first-line chemotherapy and received ICI + platinum combination therapy as adjuvant therapy. (2) Patients who are judged to be inappropriate as research subjects by the principal investigator.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Frequency of synchronous oligometastasis and origoprogression in small cell lung cancer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath